Assertio Presents First-Ever Real-World Study Showing Patient Experience with SYMPAZAN® (clobazam) Oral Film, CIV [Yahoo! Finance]
Assertio Holdings, Inc. (ASRT)
Last assertio holdings, inc. earnings: 3/9 04:02 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
patients with Lennox-Gastaut Syndrome (LGS), a severe form of childhood-onset epilepsy Study addresses lack of awareness and real-world data with oral film formulation of clobazam New data presented during poster session at 150 th Annual Meeting of the American Neurological Association SYMPAZAN is the only FDA-approved oral film formulation of clobazam for adjunctive treatment of seizures associated with LGS in patients two years of age or older BALTIMORE, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products designed to address patients' needs, today announced new data from a first-ever real-world study of SYMPAZAN (clobazam) Oral Film. The data were presented at the 150 th Annual Meeting of the American Neurological Association (ANA2025) as a poster ( click here for poster) titled “M266: Real-World Evidence Study of Patient
Show less
Read more
Impact Snapshot
Event Time:
ASRT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ASRT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ASRT alerts
High impacting Assertio Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
ASRT
News
- Quetzal Therapeutics Appoints Todd Smith as Board Member [Yahoo! Finance]Yahoo! Finance
- Assertio Holdings Inc (ASRT) Q3 2025 Earnings Call Highlights: Impressive Growth Amid Market ... [Yahoo! Finance]Yahoo! Finance
- Assertio Holdings, Inc. (ASRT) Q3 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Assertio stock rises after revenue beat [Seeking Alpha]Seeking Alpha
- Assertio Reports Third Quarter 2025 Financial Results [Yahoo! Finance]Yahoo! Finance
ASRT
Earnings
- 11/10/25 - Beat
ASRT
Sec Filings
- 11/21/25 - Form 8-K
- 11/14/25 - Form 4
- 11/12/25 - Form 4
- ASRT's page on the SEC website